Pulse Biosciences (PLSE) Other Non-Current Assets (2017 - 2026)
Pulse Biosciences (PLSE) posted quarterly Other Non-Current Assets of $691000.0 for Q4 2025, up 2.07% year-over-year from $677000.0 in Q4 2024, and down 1.99% quarter-over-quarter from $705000.0 in Q3 2025.
Pulse Biosciences (PLSE) Other Non-Current Assets (2017 - 2026) Analysis & Trends
Pulse Biosciences' Other Non-Current Assets history runs 9 years deep, the most recent figure standing at $691000.0 for Q4 2025.
- In Q4 2025, Other Non-Current Assets rose 2.07% year-over-year to $691000.0; the TTM figure through Dec 2025 stood at $691000.0 (up 2.07% YoY), while the FY2025 annual figure was $691000.0, up 2.07% from the prior year.
- Other Non-Current Assets for Q4 2025 stood at $691000.0, down from $705000.0 in the prior quarter.
- The five-year high for Other Non-Current Assets was $714000.0 in Q2 2024, with the low at $365000.0 in Q1 2021.
- The 5-year median for Other Non-Current Assets is $365000.0 (2021), against an average of $476650.0.
- The sharpest annual moves came in 2021 and 2024: Other Non-Current Assets plunged 35.05% in 2021, then soared 95.62% in 2024.
- Pulse Biosciences' Other Non-Current Assets stood at $365000.0 in 2021, then changed by 0.0% to $365000.0 in 2022, then changed by 0.0% to $365000.0 in 2023, then jumped by 85.48% to $677000.0 in 2024, then increased by 2.07% to $691000.0 in 2025.
- Business Quant data shows PLSE's Other Non-Current Assets at $691000.0 in Q4 2025, $705000.0 in Q3 2025, and $677000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | - |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 2.55 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 434.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 457.39 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 22.91 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 82.80 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 904.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 672.80 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 669.00 Mn |
| 10 | Pulse Biosciences | 3.50 Bn | 3.50 Bn | 161,000.00 | 403,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 403,000.00 |
| Dec 31, 2025 | 691,000.00 |
| Sep 30, 2025 | 705,000.00 |
| Jun 30, 2025 | 677,000.00 |
| Mar 31, 2025 | 678,000.00 |
| Dec 31, 2024 | 677,000.00 |
| Sep 30, 2024 | 646,000.00 |
| Jun 30, 2024 | 714,000.00 |
| Mar 31, 2024 | 365,000.00 |
| Dec 31, 2023 | 365,000.00 |
| Sep 30, 2023 | 365,000.00 |
| Jun 30, 2023 | 365,000.00 |
| Mar 31, 2023 | 365,000.00 |
| Dec 31, 2022 | 365,000.00 |
| Sep 30, 2022 | 365,000.00 |
| Jun 30, 2022 | 365,000.00 |
| Mar 31, 2022 | 365,000.00 |
| Dec 31, 2021 | 365,000.00 |
| Sep 30, 2021 | 365,000.00 |
| Jun 30, 2021 | 365,000.00 |